Geron Corporation (GERN): All Signs Point To Geron's Imetelstat Being The Holy Grail Of Myeloproliferative Drugs - Seeking Alpha
Here is a great article on Geron (GERN) and its anti-cancer drug that is currently in trials. I have followed Geron for years, and I own the stock. I am also planning to buy more shares. GERN could very easily be a multi-bagger stock.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment